Verastem
Drug Discovery
Verastem valuation and funding history | Last updated: December 31, 2023 | 1 funding rounds
Current Valuation
N/A
As of December 31, 2023
Total Funding Raised
N/A
Across 1 round
Last Round
PIPE
$20.6M
Last Funding
Dec 2023
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| December 31, 2023 | PIPE | $20.6M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Verastem is currently valued at N/A as of December 31, 2023.
What is Verastem Worth in 2026?
Verastem is a leading private company in the Drug Discovery sector. Track Verastem's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Verastem Valuation is Determined
Private company valuations like Verastem's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.